Monday, March 11, 2024 9:35:11 AM
Outstanding Shares 3,517,023,447 03/11/2024
Restricted 586,331,747 03/11/2024
Unrestricted 2,930,691,700 03/11/2024
Held at DTC 2,915,562,735 03/11/2024
Authorized Shares 12,000,000,000 03/08/2024
Outstanding Shares 3,517,023,447 03/08/2024
Restricted 586,331,747 03/08/2024
Unrestricted 2,930,691,700 03/08/2024
Held at DTC 2,915,562,735 03/08/2024
Authorized Shares 12,000,000,000 03/07/2024
Outstanding Shares 3,517,023,447 03/07/2024
Restricted 586,331,747 03/07/2024
Unrestricted 2,930,691,700 03/07/2024
Held at DTC 2,915,562,735 03/07/2024
Authorized Shares 12,000,000,000 03/06/2024
Outstanding Shares 3,517,023,447 03/06/2024
Restricted 586,331,747 03/06/2024
Unrestricted 2,930,691,700 03/06/2024
Held at DTC 2,915,562,735 03/06/2024
Authorized Shares 12,000,000,000 03/05/2024
Outstanding Shares 3,517,023,447 03/05/2024
Restricted 586,331,747 03/05/2024
Unrestricted 2,930,691,700 03/05/2024
Held at DTC 2,915,562,735 03/05/2024
Authorized Shares 12,000,000,000 03/04/2024
Outstanding Shares 3,517,023,447 03/04/2024
Restricted 586,331,747 03/04/2024
Unrestricted 2,930,691,700 03/04/2024
Held at DTC 2,598,765,860 03/04/2024
Authorized Shares 12,000,000,000 03/01/2024
Outstanding Shares 3,517,023,447 03/01/2024
Restricted 586,331,747 03/01/2024
Unrestricted 2,930,691,700 03/01/2024
Held at DTC 2,598,765,860 03/01/2024
SS >300m+ on 03/01/2024 update
Authorized Shares 12,000,000,000 02/28/2024
Outstanding Shares 3,200,226,572 02/28/2024
Restricted 586,331,747 02/28/2024
Unrestricted 2,613,894,825 02/28/2024
Held at DTC 2,598,765,860 02/28/2024
Authorized Shares 12,000,000,000 02/27/2024
Outstanding Shares 3,200,226,572 02/27/2024
Restricted 586,331,747 02/27/2024
Unrestricted 2,613,894,825 02/27/2024
Held at DTC 2,598,765,860 02/27/2024
Recent CBIA News
- Form 1-A-W - Withdrawal of offering statement [Regulation A] • Edgar (US Regulatory) • 09/11/2023 06:04:16 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/17/2023 04:38:54 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 07/24/2023 04:15:07 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM